Male hypogonadism (Part 1)

Main Article Content

Ye.V. Luchytskyy
V.Yе. Luchytskyy
M.D. Tronko


The first part of the review presents the current data on the prevalence of male hypogonadism, methods of diagnosing different forms of hypogonadism, describes the clinical manifestations of the most common forms of this disease.

Article Details

How to Cite
Luchytskyy, Y., V. Luchytskyy, and M. Tronko. “Male Hypogonadism (Part 1)”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 4, July 2017, pp. 281-9, doi:10.22141/2224-0721.13.4.2017.106658.


Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metabol. 2010;95:2536-9. doi: 10.1210/jc.2009-2354.

Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Springer-Verlag BBerlin Heidelberg; 2010. doi: 10.1007/978-3-540-78355-8_1.

Dohle GR, Arver S, Bettocchi C, et al. EAU Guidelines on Male Hypogonadism. EAU 2016. 26 p. Available from:

Brinkman AO. Molecular mechanisms of androgen action – a historical perspective. Methods Mol Biol. 2011;776:3. doi: 10.1007/978-1-61779-243-4_1.

de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. 2011;9:93. doi: 10.1186%2F1477-7827-9-93.

McLachlan RI, et al. Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl. 2002 Mar-Apr;23(2):149. PMID: 11868805.

Zitzmann M. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men. Nat Clin Pract Urol. 2007;4:161-6. doi: 10.1038/ncpuro0706.

Canale D, et al. Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol. (Oxf). 2005;63:356-61. doi: 10.1111/j.1365-2265.2005.02354.x.

Nieschlag E, Behre HM, editors. Testosterone: action, deficiency, substitution. Cambridge. University Press; 2004.

Greenspan FS, Strewler GJ. Basic and Clinical Endocrinology. 5 ed. 1997. pp. 404-30.

Zitzmann M, Faber S, Nieschlag Е. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006 Nov;91(11):4335-43. doi: 10.1210/jc.2006-0401.

Dreval’ AV, Red’kin YuA. Age-related hypogonadism: basic principles of diagnostics and treatment. Rossijskij Medicinskij Zhurnal. 2016;1:29-31. (In Russian).

Luchytskyi EV, Luchytskyi VE, Pylypenko VM, authors. Tron’ko MD, Bol’shova OV, editors. Porushennja statevogo dozrіvannja. Klіnіchna endokrinologіja ditjachogo ta pіdlіtkovogo vіku [Violation of the sexual ripening. Clinical endocrinology of child's and juvenile age]. Кyiv: Zdorovya Ukrajiny; 2016. pp. 497-575. (In Ukrainian).

Tüttelmann F, Gromoll J. Novel genetic aspects of Klinefelter‘s syndrome. Mol Hum Reprod. 2010 Jul;16(6):386-95. doi: 10.1093/molehr/gaq019.

Pühse G, et al. Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment. Int JAndrol. 2011 Oct;34( P2t2):e351-7. doi: 10.1111/j.1365-2605.2010.01123.x.

Nord C, et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol. 2003 Sep;44(3):3228. PMID: 12932930.

Jaaskelainen J. Molecular biology of androgen insensitivity. Mol Cel Endocrinol. 2011 Apr;352(1-3):4-12. doi: 10.1016/j.mce.2011.08.006.

Tajar A, Huhtaniemi IT, O’Neill TW, et al. EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metabol. 2012 May;97(5):1508-16. doi: 10.1210/jc.2011-2513.

Lawrence KL, Stewart F, Larson BM. Approaches to male hypogonadism in primary care. The Nurse Pract. 2017;42:32-37. PMID: 28085783. PMCID: PMC5278890. doi: 10.1097/01.NPR.0000511774.51873.da.

Wu FC, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010 Jul;363:123-135. doi: 10.1056/NEJMoa0911101.

Morgentaler A, Zitzman M, Traish AM, et al. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin Proc. 2016;91(7):881-96. doi: 10.1016/j.mayocp.2016.04.007.

Most read articles by the same author(s)

1 2 > >>